BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11098499)

  • 1. UFT plus carboplatin for head and neck cancer.
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Tomita T; Yamashita T
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):72-5. PubMed ID: 11098499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
    González-Larriba JL; Garcia Carbonero I; Sastre Valera J; Perez Segura P; Diaz-Rubio E
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):90-7. PubMed ID: 9348577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemotherapy in the treatment of head and neck cancer.
    Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
    [No Abstract]   [Full Text] [Related]  

  • 5. Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
    Colevas AD
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):86-9. PubMed ID: 9348576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy with oral tegaful and uracil for maxillary sinus carcinoma.
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J; Inuyama Y
    Oncology; 1998; 55(2):109-15. PubMed ID: 9499184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma.
    Taguchi T; Ikeda Y; Mikami Y; Kawai S; Arai Y; Mochimatsu I; Tsukuda M
    Anticancer Res; 2003; 23(1B):713-7. PubMed ID: 12680172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
    Rivera F; Vega-Villegas ME; López-Brea MF; García-Castaño A; de Juan A; Ramos FJ; Collado A; Galdós P; Rubio A; del Valle A; Rama J; Mayorga M; Sanz-Ortiz J
    Clin Transl Oncol; 2007 Jan; 9(1):40-7. PubMed ID: 17272229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
    Rivera F; Vega-Villegas ME; López-Brea MF; García-Castaño A; de Juan A; Collado A; Galdós P; Rubio A; del Valle A; Rama J; Sanz-Ortiz J
    Laryngoscope; 2004 Jul; 114(7):1163-9. PubMed ID: 15235341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy with S-1 and carboplatin for head and neck cancers].
    Watanabe A; Taniguchi M; Tsujie H
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():155-9. PubMed ID: 16897993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT Study Group].
    Tsukuda M; Ogasawara H; Kaneko S; Komiyama S; Horiuchi M; Inuyama Y; Uemura T; Uchida M; Kamata S; Okuda M
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1169-77. PubMed ID: 8031158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
    Czito BG; Cohen DP; Kelsey CR; Lockhart AC; Bendell JC; Willett CG; Petros WP; D'Amico TA; Truax R; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1066-72. PubMed ID: 17881149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
    Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Satake K; Taguchi T; Takahashi M; Kawakami M; Hanamura H; Watanabe M; Utsumi A
    Auris Nasus Larynx; 2009 Oct; 36(5):547-54. PubMed ID: 19097833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].
    Hiramatsu K; Kato K; Hirata A; Matsuba H; Hara T; Ito T; Miyata T; Akagawa T; Kutsuna Y; Machiki Y; Fujioka S
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):443-6. PubMed ID: 17353640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
    Soh J; Toyooka S; Okumura N; Nakamura H; Nakata M; Yamashita M; Sakamoto J; Aoe M; Hotta K; Morita S; Date H
    Int J Clin Oncol; 2019 Nov; 24(11):1367-1376. PubMed ID: 31312931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H; Tsukuda M; Taguchi T
    Acta Otolaryngol; 2007 Oct; 127(10):1099-104. PubMed ID: 17851890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.